Terms: = Liver cancer AND uPA
221 results:
1. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
2. circPSD3 is a promising inhibitor of upa system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.
Xu L; Wang P; Li L; Li L; Huang Y; Zhang Y; Zheng X; Yi P; Zhang M; Xu M
Mol Cancer; 2023 Oct; 22(1):174. PubMed ID: 37884951
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC.
Boslem E; Reibe S; Carlessi R; Smeuninx B; Tegegne S; Egan CL; McLennan E; Terry LV; Nobis M; Mu A; Nowell C; Horadagoda N; Henstridge DC; Mellett NA; Timpson P; Jones M; Denisenko E; Forrest ARR; Tirnitz-Parker JEE; Meikle PJ; Rose-John S; Karin M; Febbraio MA
Sci Adv; 2023 Sep; 9(37):eadh0831. PubMed ID: 37703359
[TBL] [Abstract] [Full Text] [Related]
4. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.
Evrard C; Ingrand P; Rochelle T; Martel M; Tachon G; Flores N; Randrian V; Ferru A; Haineaux PA; Goujon JM; Karayan-Tapon L; Tougeron D
Dig Liver Dis; 2023 Nov; 55(11):1562-1572. PubMed ID: 37308396
[TBL] [Abstract] [Full Text] [Related]
5. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
Ye JC; Hsieh YS; Chen PN; Liu JY; Hsieh YH
Drug Dev Res; 2023 Jun; 84(4):767-776. PubMed ID: 37005497
[TBL] [Abstract] [Full Text] [Related]
6. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids.
Middelkoop MA; de Lange ME; Clark TJ; Mol BWJ; Bet PM; Huirne JAF; Hehenkamp WJK
Hum Reprod; 2022 May; 37(5):884-894. PubMed ID: 35143669
[TBL] [Abstract] [Full Text] [Related]
8. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B.
Argirion I; Pfeiffer RM; Lam TK; O'Brien TR; Yu K; McGlynn KA; Petrick JL; Pinto L; Chen CJ; Lee MH; Hildesheim A; Yang HI; Koshiol J
Sci Rep; 2021 Nov; 11(1):21194. PubMed ID: 34782638
[TBL] [Abstract] [Full Text] [Related]
9. Phase III long-term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids.
Osuga Y; Nakano Y; Yamauchi Y; Murakawa H
J Obstet Gynaecol Res; 2021 Sep; 47(9):3269-3278. PubMed ID: 34109697
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis.
Kounidas G; Kastora SL; Barnott E; Black L; Robinson-Burke T; Gould A; Morgan D; Urquhart G; Poobalan A; Jack A
J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102173. PubMed ID: 34082168
[TBL] [Abstract] [Full Text] [Related]
11. Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.
Kim W; Kang JA; Park M; Jeong PH; Kim YJ; Cho Y; Park SG; Kim YC
J Med Chem; 2021 May; 64(9):5500-5518. PubMed ID: 33887912
[TBL] [Abstract] [Full Text] [Related]
12. Management of women with uterine fibroids in reproductive center: retrospective analysis of clinical and reproductive outcomes.
Miriello D; Galanti F; Meneghini C; Fabiani C; Dal Lago A; Schiavi MC; Rago R
Minerva Obstet Gynecol; 2022 Apr; 74(2):130-136. PubMed ID: 33876897
[TBL] [Abstract] [Full Text] [Related]
13. Systematic evaluation of structure-property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride.
Buckley BJ; Aboelela A; Majed H; Bujaroski RS; White KL; Powell AK; Wang W; Katneni K; Saunders J; Shackleford DM; Charman SA; Cook GM; Kelso MJ; Ranson M
Bioorg Med Chem; 2021 May; 37():116116. PubMed ID: 33799173
[TBL] [Abstract] [Full Text] [Related]
14. Use of Ulipristal Acetate and Risk of liver Disease: A Nationwide Cohort Study.
Yoon EL; Yuk JS
J Clin Endocrinol Metab; 2021 May; 106(6):1773-1782. PubMed ID: 33567071
[TBL] [Abstract] [Full Text] [Related]
15. Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells.
Osawa M; Matsuda Y; Kinoshita Y; Wakai T
Anticancer Res; 2021 Feb; 41(2):645-660. PubMed ID: 33517269
[TBL] [Abstract] [Full Text] [Related]
16. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.
Conde de la Rosa L; Garcia-Ruiz C; Vallejo C; Baulies A; Nuñez S; Monte MJ; Marin JJG; Baila-Rueda L; Cenarro A; Civeira F; Fuster J; Garcia-Valdecasas JC; Ferrer J; Karin M; Ribas V; Fernandez-Checa JC
J Hepatol; 2021 Jun; 74(6):1429-1441. PubMed ID: 33515644
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.
Tao P; Gao L; Li H; Wang B; Li X; Zhang Y; Chen H
Medicine (Baltimore); 2020 Dec; 99(52):e23841. PubMed ID: 33350772
[TBL] [Abstract] [Full Text] [Related]
18. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ekanem E; Talaulikar V
Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
[TBL] [Abstract] [Full Text] [Related]
19. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and cancer Cells Regulates Pancreatic cancer Metastasis.
Geng Y; Fan J; Chen L; Zhang C; Qu C; Qian L; Chen K; Meng Z; Chen Z; Wang P
Cancer Res; 2021 Jan; 81(1):64-76. PubMed ID: 33172931
[TBL] [Abstract] [Full Text] [Related]
20. A multi-centre, randomized, non-inferiority trial to compare ulipristal with standard surgical treatment in women with symptomatic uterine fibroids: Protocol of the MYOMEX-2 trial.
Middelkoop MA; Huirne JAF; van der Weide MCJ; Bosmans JE; Hehenkamp WJK;
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():63-69. PubMed ID: 33171419
[TBL] [Abstract] [Full Text] [Related]
[Next]